TP53 and breast carcinoma: It has been reported that CSN-specific phosphorylation of TP53 dedicates the protein to rapid degradation by the ubiquitin-26S proteasome system (Bech-Otschir et al. 2001), and thus we hypothesized that GPS1 could contribute to breast cancer development by affecting the stability and mutational status of TP53.